The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceut...
- The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug Dupixent to treat nasal polyps, marking the third major use for the injectable medicine.
The expanded label, which could significantly boost annual sales, is for use with other medicines to treat patients suffering from chronic rhinosinusitis with nasal polyps, the companies said in a joint statement. Chronic rhinosinusitis is a persistent inflammation of the mucous membranes in the nose and sinuses that can lead to development of nasal polyps - teardrop shaped, noncancerous growths that can cause irritation and swelling.
Cowen analyst Yaron Werber, citing the drug’s effectiveness and clean safety profile, forecast that the additional approval will add $956.3 million to Dupixent’s worldwide sales in 2024, calling it “a sizable but overlooked market with few entrenched competitors.”Data released earlier this month showed Roche AG and Novartis’ Xolair is able to treat patients with chronic rhinosinusitis with nasal polyps, potentially pitting it against Dupixent in this patient group.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opinion | The FDA’s Challenge on E-CigsOpinion: The dramatic rise of e-cig use by young people demands FDA action, writes former FDA commissioner ScottGottliebMD
Read more »
FDA issues warnings to companies selling kratom products for opioid addictionThe federal agency says the companies are using websites and social media to illegally market the popular herbal supplement by making unproven claims.
Read more »
FDA issues warnings to companies that claim an herbal drug can cure opioid addictionThe Food and Drug Administration recently issued warnings to two businesses that are illegally marketing and making 'unproven' claims that their products, which contain a drug called kratom, can treat or cure opioid addiction and withdrawal.
Read more »
FDA Approves Second Drug For Women With Low LibidoA new drug, dubbed by some as a female version of Viagra, has just been approved by the FDA to treat sexual desire in women with HSDD, an unexplained form of low libido.
Read more »
The FDA Wouldn't Let This 24-Year-Old Give Blood — So He Donated A Kidney Instead'It's something that really didn’t impact me much, but it can really make a difference for somebody else,' Barton Lynch says
Read more »
San Francisco Passes E-Cigarette BanIf signed into law, the city would restrict sales of the products until they’re approved by the FDA
Read more »